{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-308372","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2022-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.772881+00:00","generated_at":"2026-06-21T02:58:31.803262+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"HCA Healthcare amends bylaws to update director nomination and proxy solicitation requirements","bullets":["Board adopted Third Amended and Restated Bylaws effective December 19, 2022.","Amendment revises Article II, Section 11 to require compliance with SEC Rule 14a-19 for director nominations and proxy solicitations.","Technical, ministerial, and conforming changes made to align with recent Delaware General Corporation Law amendments."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-308372","json":"https://secwatch.observer/filing/0001193125-22-308372.json","markdown":"https://secwatch.observer/filing/0001193125-22-308372.md","text":"https://secwatch.observer/filing/0001193125-22-308372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/0001193125-22-308372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/d385362d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T02:58:31.803262+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f0539f909b03c5f43e3034c69f0d08e58b4ff8f2","claim":"HCA Healthcare, Inc.: Amended and restated bylaws to revise director nomination and proxy solicitation requirements, including compliance with Rule 14a-19, and incorporate technical conforming changes (effective 2022-12-19).","evidence_excerpt":"On December 19, 2022, the Board of Directors (the “Board”) of HCA Healthcare, Inc. (the “Company”), based on the recommendation of the Nominating and Corporate Governance Committee of the Board, adopted an amendment and restatement of the Company’s Second Amended and Restated Bylaws (as so amended, the “Third Amended Bylaws”), which became effective immediately upon adoption by the Board.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312522308372/0001193125-22-308372-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2022-12-19"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}